Heartflow (NASDAQ:HTFL) CEO John C.M. Farquhar Sells 22,562 Shares

Key Points

• CEO John C.M. Farquhar sold 22,562 shares on April 10 at an average price of $26.72 for $602,856.64 under a pre‑arranged Rule 10b5‑1 plan, reducing his stake by 3.95% to 549,163 shares (≈$14.67M).
• HeartFlow shares rose 5.9% to $29.05 during midday trading, with a market capitalization of about $2.49 billion, a 52‑week range of $20.13–$41.22, and a negative P/E of -14.60.
• Analysts show a consensus rating of “Moderate Buy” with a $37.67 average target (five Buys, two Holds, one Sell), amid mixed recent price‑target revisions from major brokerages.

Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) CEO John C.M. Farquhar sold 22,562 shares of the firm's stock in a transaction on Friday, April 10th. The stock was sold at an average price of $26.72, for a total transaction of $602,856.64. Following the transaction, the chief executive officer directly owned 549,163 shares of the company's stock, valued at approximately $14,673,635.36. This trade represents a 3.95% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Wednesday, March 18th, John C.M. Farquhar sold 9,725 shares of Heartflow stock. The shares were sold at an average price of $25.00, for a total transaction of $243,125.00.
• On Tuesday, March 10th, John C.M. Farquhar sold 12,837 shares of Heartflow stock. The stock was sold at an average price of $22.66, for a total value of $290,886.42.
• On Tuesday, February 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $27.46, for a total value of $619,552.52.

Heartflow Stock Up 5.9%

Shares of HTFL traded up $1.62 during mid-day trading on Tuesday, reaching $29.05. The company had a trading volume of 1,283,628 shares, compared to its average volume of 1,487,298. The stock has a market capitalization of $2.49 billion and a P/E ratio of -14.60. Heartflow, Inc. has a 52-week low of $20.13 and a 52-week high of $41.22. The stock has a 50 day moving average of $24.69 and a two-hundred day moving average of $29.59.

Institutional Trading of Heartflow

A number of institutional investors and hedge funds have recently made changes to their positions in HTFL. Caitong International Asset Management Co. Ltd purchased a new position in shares of Heartflow during the 4th quarter valued at approximately $27,000. TFC Financial Management Inc. purchased a new stake in Heartflow in the 3rd quarter worth $40,000. Russell Investments Group Ltd. acquired a new position in Heartflow during the fourth quarter worth $45,000. Legal & General Group Plc purchased a new position in Heartflow during the third quarter valued at $59,000. Finally, Strs Ohio purchased a new position in Heartflow during the fourth quarter valued at $99,000.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on HTFL. JPMorgan Chase & Co. dropped their price objective on shares of Heartflow from $40.00 to $35.00 and set an "overweight" rating on the stock in a research note on Thursday, March 19th. Canaccord Genuity Group increased their price target on shares of Heartflow from $40.00 to $43.00 and gave the stock a "buy" rating in a report on Thursday, March 19th. Weiss Ratings restated a "sell (d)" rating on shares of Heartflow in a research report on Monday, December 29th. Finally, Wells Fargo & Company decreased their price objective on shares of Heartflow from $38.00 to $35.00 and set an "overweight" rating for the company in a research report on Thursday, March 19th. Five analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $37.67.

Heartflow Company Profile

HeartFlow, Inc NASDAQ: HTFL is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.